We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Enzyme Found that Enables Cancer Cell Mobility

By Biotechdaily staff writers
Posted on 15 Nov 2002
Researchers seeking to understand how cancer cells metastasize and travel through the body have identified an enzyme, phosphatidylinositol phosphate kinase isoform (PIPKIy661), that appears to be required for the formation of points of focal adhesion, which are specialized clusters of proteins on the cell surface that enable the cells to migrate. More...
Their findings were reported in the November 7, 2002, issue of Nature.

"What we have identified is an enzyme that regulates the assembly of focal adhesions,” explained senior author Dr. Richard Anderson, professor of pharmacology at the University of Wisconsin (Madison, USA; www.wisc.edu). "Researchers have been looking for this enzyme for years.”

PIPKIy661 was found to interact directly with two key proteins (FAK and talin) involved in focal adhesion assembly. At the same time, PIPKIy661 also generated an important second messenger (P14,5P2) that regulated a number of proteins inside the cell and stimulated their ability to form focal adhesions.

Inhibition of PIPKIy661 activity would prevent focal adhesion assembly, and cancer cells would be rendered immobile, thereby unable to migrate to other parts of the body. "Exactly how cancer cells metastasize has been poorly understood,” said Dr. Anderson. "This discovery is a real breakthrough that could really have an impact.”



Related Links:
University of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Electrolyte Analyzer
BKE-B
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.